Study on Risk Factors for Adenomyosis Progression
Risk Factors Associated With the Progression of Adenomyosis
Recruiting
Observational Study
Adenomyosis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 55
- Sex
- Female
- Study type
- Observational
- Participants needed
- 258 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Who this trial is looking for
This trial is looking for women aged 18 to 55 who have adenomyosis. Participants will have their condition monitored using transvaginal ultrasound.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 18 and 55 years old.
- I have been diagnosed with adenomyosis.
- I can provide informed consent.
You may not be able to join if
- I am undergoing a hysterectomy.
- I have never had sexual intercourse.
- I cannot tolerate transvaginal ultrasound.
- I have a history of gynaecological cancer.
- I have been pregnant or given birth in the last 6 months.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Adenomyosis is a gynaecological disorder with a high prevalence in women of childbearing age and is characterised by the presence of endometrial glands and stroma within the myometrium, associated or not with hypertrophy and hyperplasia of the surrounding myometrium. Adenomyosis may cause pelvic pain and/or abnormal uterine bleeding.
Transvaginal ultrasound (TVUS) is considered the main non-invas…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged between 18 and 55 years;
* Presence of at least two direct and indirect signs according to the MUSA classification
* Obtaining informed consent
Exclusion Criteria:
* Patients undergoing hysterectomy;
* Virgo patients;
* Patients reporting intolerance to transva…
Contacts